1.
J Pediatr
; 120(2 Pt 1): 277-80, 1992 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-1735829
RESUMEN
Long-term studies of a child with Gaucher disease indicated that the response to treatment with macrophage-targeted glucocerebrosidase (glucosylceramidase) is dose dependent, and that the hematologic response precedes the skeletal response.